|
|
|
|
|
|
|
|
The IMF Concise Review of the Disease and Treatment Options is an overview of myeloma, with a discussion of the pathophysiology, clinical features, and treatment options. It is hoped that the information will be helpful to health professionals and patients alike. |
|
|
|
The IMWG consists of 109 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects with a goal to improve myeloma treatment options and diagnostic systems. |
|
|
|
Summaries from the workshop sessions in Kos, Greece on 5–30 June, 2007 |
|
|
|
New and updated data on the use of novel therapeutics in combination therapy in patients with newly diagnosed or relapsed/refractory multiple myeloma were presented at the 2007 meeting of the American Society of Clinical Oncology (ASCO), June 1 through 5, in Chicago, Illinois. |
|
|
|
Download and read the PDF of our summary of the 48th Annual Meeting of the American Society of Hematology(ASH). |
|
|
|
The IMF is pleased to bring you CITINGS, a quarterly publication featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma. |
|
|
|
|
These guidelines encompass both the published literature and expert opinions. Recommendations based upon expert opinions are identified as such. The intent is for the guidelines to be international in scope, plus provide recommendations for both clinical practice and research approaches. This article appeared in The Hematology Journal (2003) 4, 379-398. |
|
|
|
The Myeloma Matrix provides updated information about drugs beginning with pre-clinical developments and tracks drugs as they proceed through Phases I – III of clinical trials, to FDA approval. |
|
back
step 1: get the correct diagnosis
publications
print
back to top